202 top medical experts on Hepatic Porphyrias across 26 countries and 13 U.S. states, including 25 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Hepatic Porphyrias: A group of metabolic diseases due to deficiency of one of a number of liver enzymes in the biosynthetic pathway of heme. They are characterized by the accumulation and increased excretion of porphyrins or its precursors. Clinical features include neurological symptoms (porphyria, acute intermittent), cutaneous lesions due to photosensitivity (porphyria cutanea tarda), or both (hereditary coproporphyria). Hepatic porphyrias can be hereditary or acquired as a result of toxicity to the hepatic tissues.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Genetic Skin Diseases (3,548), Porphyrias (556), Liver Diseases (3,550) and Narrower Categories: Acute Intermittent Porphyria (1,032), Erythropoietic Protoporphyria (660), Hepatoerythropoietic Porphyria (34), Hereditary Coproporphyria (120), Porphyria Cutanea Tarda (588), Variegate Porphyria (206).
  4. Clinical Trials ClinicalTrials.gov : at least 15 including 2 Active, 7 Completed, 2 Recruiting
  5. Synonyms: Hepatic Porphyria


  

        

                    


    Computing Expert Listing ...

);